However, exosomes (but not microvesicles) isolated from patients with acute hepatitis C at week 4 of treatment with PEG-IFN-α and ribavirin had a relevant inhibitory effect of HCV replication (Figure 7A). This evidence concerns the gene IFNA2 and hepatitis C virus infection.